Container for pharmaceutical substance to be administered nasally

Description

FIG. 1 is a perspective view of a container for pharmaceutical substance to be administered nasally, as viewed from the front, showing my new design;

FIG. 2 is a perspective view thereof, as shown from the rear;

FIG. 3 is a right side elevational view thereof, the left side elevational view being a mirror image thereof;

FIG. 4 is a front elevational view thereof;

FIG. 5 is a rear elevational view thereof; and,

FIG. 6 is a top plan view thereof.

Claims

The ornamental design for container for pharmaceutical substance to be administered nasally, as shown and described.

---

Inventors:	Renfrew; Bruce (Leicester, GB)
Assignee:	Glaxo Group Limited (Middlesex, GB)
Appl. No.:	D/124,933
Filed:	June 14, 2000

---

Foreign Application Priority Data

---

Dec 20, 1999 [GB]			2088944

Current U.S. Class:	D24/115
Current International Class:	2402
Field of Search:	;D24/110,115,119 ;D9/520,521,529 ;D28/85 ;220/206,205,212,189,295,302,213,173,184 ;128/200.14

---

References Cited [Referenced By]

---

U.S. Patent Documents

3342379	September 1967	Foley
D345630	March 1994	Chevassus
5632420	May 1997	Lohrman et al.
D392890	March 1998	Zaksenberg
D397037	August 1998	Negre
5996850	December 1999	Morali et al.
D444227	June 2001	Hennemann et al.

Foreign Patent Documents

	813302		Jun 1991		JP
	831531		Mar 1992		JP
	869158		May 1993		JP
	952618		Jan 1999		JP

Primary Examiner: Simmons; Ian
Attorney, Agent or Firm: Darby & Darby